Wall St. Icon: “If you wait on this, it will already be too late”

If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.

Steven B. Miller net worth and biography

Steven Miller Biography and Net Worth

EVP of The Cigna Group

Dr. Steve Miller serves as Cigna's Chief Clinical Officer, and leads all of the company’s clinical policy, quality, and performance efforts. He formerly served as Senior Vice President and Chief Medical Officer for Express Scripts. Dr. Miller engages with all participants in the pharmaceutical supply chain, assuring that clinical quality and efficacy are a critical part of the value we deliver.

Dr. Miller is the executive sponsor of many client relationships, partnering with clients to identify unique approaches and innovative solutions for their needs. In previous roles at Express Scripts he has had oversight of the Pharmacy & Therapeutics committee, Medical Affairs team, and Government Affairs.

Dr. Miller received his medical degree from the University of Missouri-Kansas City, and he trained in the Pathology and Research fellowship at the University of Alabama at Birmingham and in cardiology at the University of California, San Francisco. He also earned his MBA at the Olin School of Business at Washington University in St. Louis.

What is Steven B. Miller's net worth?: The estimated net worth of Steven B. Miller is at least $9.82 million as of January 6th, 2021. Dr. Miller owns 35,076 shares of The Cigna Group stock worth more than $9,823,385 as of December 24th. This net worth estimate does not reflect any other assets that Dr. Miller may own. Learn More about Steven B. Miller's net worth.
How do I contact Steven B. Miller?: The corporate mailing address for Dr. Miller and other The Cigna Group executives is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The Cigna Group can also be reached via phone at (860) 226-6000 and via email at [email protected]. Learn More on Steven B. Miller's contact information.
Has Steven B. Miller been buying or selling shares of The Cigna Group?: Steven B. Miller has not been actively trading shares of The Cigna Group over the course of the past ninety days. Most recently, Steven B. Miller sold 8,972 shares of the business's stock in a transaction on Wednesday, January 6th. The shares were sold at an average price of $210.00, for a transaction totalling $1,884,120.00. Following the completion of the sale, the executive vice president now directly owns 35,076 shares of the company's stock, valued at $7,365,960. Learn More on Steven B. Miller's trading history.
Who are The Cigna Group's active insiders?: The Cigna Group's insider roster includes Mary Agolglia Hoeltzel (VP), Lisa Bacus (EVP), David Cordani (President, CEO & Chairman of the Board), William DeLaney, III (Director), Noelle Eder (EVP and Global Chief Information Officer), Brian Evanko (CFO), Brian Evanko (Exec. VP & CFO ), Eric Foss (Director), Elder Granger (Director), Isaiah Harris, Jr. (Chairman), Mary Hoeltzel (CAO), Nicole Jones (EVP), Matthew Manders (Insider), Thomas McCarthy (CFO), Steven Miller (EVP), Alan Muney (EVP), John Murabito (EVP), Everett Neville (EVP), Eric Palmer (CFO), John Partridge (Director), William Roper (Director), Cynthia Ryan (EVP), Jason Sadler (President, International Health), Paul Sanford (EVP), Michael Triplett (Insider), Timothy Wentworth (CEO), and Donna Zarcone (Director). Learn More on The Cigna Group's active insiders.
Are insiders buying or selling shares of The Cigna Group?: During the last year, insiders at the health services provider sold shares 17 times. They sold a total of 139,823 shares worth more than $48,194,208.52. The most recent insider tranaction occured on August, 19th when Director William J Delaney III sold 2,691 shares worth more than $922,151.88. Insiders at The Cigna Group own 0.7% of the company. Learn More about insider trades at The Cigna Group.
Information on this page was last updated on 8/19/2024.

Steven B. Miller Insider Trading History at The Cigna Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/6/2021	Sell	8,972	$210.00	$1,884,120.00	35,076
2/11/2020	Sell	7,145	$212.15	$1,515,811.75	32,071

Steven B. Miller Buying and Selling Activity at The Cigna Group

The Cigna Group Company Overview

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Today's Range

Now: $280.06

$277.03

$280.75

50 Day Range

MA: $317.88

$265.51

$358.56

2 Week Range

Now: $280.06

$262.03

$370.83

Volume

669,265 shs

Average Volume

1,631,462 shs

Market Capitalization

$77.90 billion

P/E Ratio

26.42

Dividend Yield

2.02%

Beta

0.5

Wall St. Icon: “If you wait on this, it will already be too late”

From InvestorPlace | Ad